Brinzolamide

布林佐胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBrinzolamide
Drug Alias Name布吲佐胺Brinzolamidum布林唑胺Brinzolamida派立明 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase II inhibitors
TargetsCarbonic anhydrase II
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1998/04/01
Country/TerritoryUnited StatesRussian FederationIndia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesSandozAlconSun Pharmaceutical Industries Ltd +[4] 
Inactive CompaniesActavis IncBausch & Lomb IncorporatedPadagis LLC
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsGlaucoma

Other Information

ATC CodeS01EC04
Related LinksWikipediaDrugBankKEGG